Contents 5 dk okuma
Important Note
This page is not medical advice. Although research on NMN is promising, most of it is based on animal studies. It should not be used to treat any health problem. Consult a healthcare professional.
What is NMN?
NMN (Nicotinamide Mononucleotide) is a nucleotide that occurs naturally in the body and is a direct precursor to the production of NAD+ (nicotinamide adenine dinucleotide). NAD+ is a critical coenzyme that plays a role in more than 500 biological reactions, from cellular energy production to DNA repair, from activation of sirtuins to epigenetic regulation.
Here's the problem: NAD+ levels drop dramatically with age. NAD+ levels that decline with age (significantly from roughly middle age in various tissues) are associated with mitochondrial dysfunction, increased oxidative stress, and decreased DNA repair capacity. NMN is one of the most efficient and bioavailable ways to replenish these diminishing NAD+ reserves; It quickly passes into the bloodstream after oral intake and participates in NAD+ synthesis in tissues.
Harvard medical school professor David Sinclair Why Aging is a Disease He has stated in his book (Lifespan) and in his public statements that he uses various NAD+ supplements, including NMN, in his personal protocol. This contributed to the molecule gaining popular attention. However, individual n=1 experiences cannot replace clinical evidence.
Mechanism of Effect
After NMN is transported into the cell way of salvage It rapidly participates in NAD+ synthesis via In this pathway, NMN is converted into NAD+ molecule by the enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase). Increased NAD+ activates many biological systems, especially sirtuins and PARP enzymes.
| mechanism | road | Biological Result |
|---|---|---|
| NAD+ Synthesis | Salvage route: NMN → NAD+ | Cellular energy increase |
| Sirtuin Activation | SIRT1, SIRT3, SIRT6 | DNA repair, inflammation reduction |
| PARP inhibition (indirect) | NAD+ protection | More NAD+ use for genomic protection |
| Mitochondrial Complex I | Electron transport chain | ATP production increases |
| Neuronal Energy | brain cell metabolism | Cognitive function support |
Clinical Evidence
Although NMN research has gained momentum in recent years, the majority of human studies are still in the early stages. Highlight findings:
- Yoshino et al. (2021, Science): Double-blind RCT in prediabetic, overweight/obese postmenopausal women. Daily 250 mg NMN supplementation significantly improved muscle insulin sensitivity and skeletal muscle NAD+ utilization capacity. This effect was not observed in the placebo group.
- Liao et al. (2021): In a randomized study conducted in amateur runners, the effects of NMN supplementation on aerobic capacity were examined; Improvements in aerobic capacity have been reported at higher doses.
- Irie et al. (2020, Japan): Dose escalation safety study conducted in healthy men; It showed that the 500 mg dose of NMN was well tolerated and significantly increased the levels of NMN and NAD+ in the blood.
- Mills et al. (2016, Cell Metabolism): Long-term NMN supplementation in aged mice; A rejuvenation-like profile was observed in many parameters, including energy metabolism, eye function, bone density and insulin sensitivity. It should be noted that this is animal data.
⚠ Research Limitations
Existing human studies have small sample sizes and short follow-up periods. Direct transfer of animal data to humans is not always possible. There is still insufficient strong evidence for cognitive benefits in healthy young individuals. Important point to note in the context of David Sinclair: individual investigator experiences do not constitute clinical evidence.
Dosage Protocol
Doses used in human studies range widely. The table below is based on research findings and common usage practices:
| Intended Use | Dose | Timing |
|---|---|---|
| General anti-aging | 250–500 mg/day | In the morning, on an empty stomach |
| intensive protocol | 500–1000 mg/day | Morning, divided doses |
| Elderly individuals (60+) | 500–1000 mg/day | Evaluating with the doctor |
NR vs NMN comparison: Nicotinamide riboside (NR) is also a widely used NAD+ precursor. Both molecules participate in NAD+ synthesis via salvage; NMN is a larger molecule and NR has a more extensive clinical research base. The difference in practical effectiveness is debatable. In the long term, cost-effectiveness evaluation comes to the fore in the choice between the two.
Form: Sublingual powders may increase bioavailability; However, adequate absorption has also been reported in capsule forms. Freeze-dried (lyophilized) forms are more resistant to heat. Store the products in a cool and dark environment.
Safety and Side Effects
In the short term (up to 1 year), NMN supplementation appears safe. Irie et al. Multiple safety studies, including (2020), did not report serious side effects. However, points to consider:
- Mild nausea and diarrhea - may occur, especially with high doses (1000 mg and above); Reducing the dose or taking it with food usually solves the problem
- Long-term human data (5 years and beyond) not yet available
- Theoretical cancer concern: The hypothesis that an increase in NAD+ may also feed cancer cells has been brought to the fore. Available data do not confirm this concern; However, individuals undergoing active cancer treatment should avoid the use of NMN and consult with their oncology team.
- There is insufficient safety data during pregnancy and breastfeeding; Use should be avoided
Regulatory Status (US)
The legal status of NMN in the United States has fluctuated. The FDA stated that NMN was excluded from the definition of a food supplement in 2022 on the grounds that it had previously been investigated as a drug (MIB-626). Following industry objections and a lawsuit, the FDA reversed its stance in 2025 and declared that NMN could legally be included in food supplements. This process demonstrates that the regulatory status of NMN may vary by country and over time. (This does not directly affect the food supplement status in Türkiye.)
Sources
- Yoshino M, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229. PubMed · PMID 33888596
- Irie J, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal, 67(2), 153–160. PubMed · PMID 31685720
- Mills KF, et al. (2016). Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metabolism, 24(6), 795–806. PubMed · PMID 28068222
- Liao B, et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners. Journal of the International Society of Sports Nutrition, 18(1), 54. Search PubMed (match unverified)
Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory
Frequently Asked Questions
NMN (Nicotinamide Mononucleotide) is the direct precursor of NAD+ coenzyme in the body. As NAD+ decreases with age, cellular energy production, DNA repair, and mitochondrial function also weaken. NMN supplementation aims to positively affect cellular energy metabolism, sirtuin enzymes that support anti-aging processes, and neuronal metabolism by replenishing these decreasing NAD + reserves.
The most commonly used dose range in clinical studies is 250–500 mg per day, and some protocols go up to 1000 mg per day. For general anti-aging purposes, it is a common approach to start with 250–500 mg in the morning on an empty stomach. High doses should not be used in individuals over 60 years of age or in the presence of chronic disease without consulting a doctor.
Available short-term safety studies show that NMN supplementation is well tolerated. The most commonly reported side effects are mild nausea and diarrhea; These usually occur with high doses (1000 mg and above) and lowering the dose or taking it with food solves the problem. Long-term (5 years and beyond) human data is not yet available. Individuals undergoing active cancer treatment and pregnant women should consult their physicians before using NMN.
NMN is sold as a food supplement in Türkiye; It is not a prescription drug. It can be found in pharmacies, health stores and various e-commerce platforms. However, it is important to buy from reliable suppliers who offer COA (certificate of analysis) for product quality and purity; The supplement industry is less tightly regulated than the pharmaceutical industry.
Although the increase in blood NAD+ levels becomes measurable within the first days after NMN ingestion, subjective changes are usually noticeable within 2–4 weeks. While a relatively earlier improvement in energy level and exercise capacity is reported, longer-term and regular use is required for cognitive clarity and anti-aging effects. Individual responses may vary significantly depending on age, baseline NAD+ level, and general health status.
